Biopharmaceutical Sciences

In Clinical Pharmacology and Biopharmaceutics track we will discuss about the rational drug management of cancer, diabetes and cardiovascular disorders, and Management of psychiatric disorders and autoimmune disorders. Along with clinical trials Bioavailability and bioequivalence studies also plays major role in clinical research. The global market for Biopharmaceutics in 2013 was $305.1 million, which is expected to reach about $326.3 million by year-end 2014. The projected PAT instrumentation market is expected to be valued at around $450.6 million by 2019 at a compound annual growth rate (CAGR) of 6.7% for the period of 2014 to 2019.

Market Analysysi:

The global biopharmaceuticals market is estimated to reach USD 341.16 billion in 2023. The market is expected to register a CAGR of 8.5% during the forecast period (2018 – 2023). North America dominates the market due to rapid technological advancements. Opportunities in biopharmaceuticals have been increasing over the past decade. The efficacy and the safety of the drugs are some of the key product features that drive the market’s growth. There have been biopharmaceutical products that are improving the quality of life and reducing the death rates in patients with HIV/AIDs, cancer, cystic fibrosis, rheumatoid arthritis.

Related Industries: Anavex Life Sciences, Bayhill Therapeutics, Biocon, Cephalon, Halozyme Therapeutics, Immunex, Proteolix, Tanox, Xoma Corporation.

Association and societies: Association of the British Pharmaceutical Industry (ABPI), International Association for Pharmaceutical Technology(APV), National Pharmacy Association (NPA), Dutch Society for Clinical Pharmacology & BiopharmacyEuropean Association of Clinical Pharmacology and Therapeutics (EACPT), The International Society for Biopharmaceutical Statistics (ISBS), Chinese American Biopharmaceutical Society

 

 

 

    Related Conference of Biopharmaceutical Sciences

    Biopharmaceutical Sciences Conference Speakers